Details


Main resources

You can consult :


https://www.snfcp.org/fiches-preoperatoires-officielles/fistules-et-suppurations-informations-pre-operatoires/informations-avant-traitement-par-injection-de-cellules-souches-mesenchymateuses-allogeniques-dorigine-adipocytaire-des-fistules-anales-de-la-maladie-de-crohn/
2022
France
patient education handout
Anorectal Fistula
Mesenchymal Stem Cells
stem cell
anal fistula
crohn's disease, nos
rectal fistula
Injectable Dosage Form
anal fistula
anus diseases
Allogeneic Cells
injections
Anus Fistula, CTCAE
Injection Method of Administration
Crohn Disease
CDISC Define-XML Origin Source Terminology
Allogeneic Adipose-derived Mesenchymal Stem Cells
injection, nos
Injection Route of Administration
crohn disease
Inject

---
Summary Basis of Decision (SBD) for Prochymal
Remestemcel-L, Adult Human Mesenchymal Stem Cells (hMSCs) 100 106 hMSCs per 15 mL, cell suspension
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00118
2012
false
Canada
French
English
Remestemcel-L
drug information
Product containing human mesenchymal stem cell (medicinal product)
Human mesenchymal stem cell (substance)
Mesenchymal Stem Cells
drug approval
canada
graft vs host disease
acute disease
child
treatment outcome
drug compounding
infusions, intravenous
drug evaluation
risk assessment

---
http://www.stromalab.fr/
France
French
research structure
Mesenchymal Stem Cells

---
Nous contacter.
15/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.